Medgenics (MDGN) Misses Q1 EPS by 8c
Tweet
Share
E-mailGet Alerts MDGN Hot Sheet
Join SI Premium – FREE
Medgenics (NYSE: MDGN) reported Q1 EPS of ($0.34), $0.08 worse than the analyst estimate of ($0.26).
For earnings history and earnings-related data on Medgenics (MDGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rivian reports record Q3 deliveries, beats estimates, shares rise
- LTC Properties (LTC) PT Raised to $52 at RBC Capital
- DBS cuts Sea target as Shopee spending weighs on profit growth
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
